161 followers
Long-Term Therapeutic Efficacy of Intravenous AAV-Mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1. https://t.co/G9k42DvX4R
Long-Term Therapeutic Efficacy of Intravenous AAV-Mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1. https://t.co/G9k42DvX4R
@MassGeneral Shame ok u. 👎👎👎 Stop wasting autism research $ on non ASD conditions. Trying HELPING the 1,000s of ASD patients u have. ⭐️Long-Term Therapeutic Efficacy of Intravenous AAV-Mediated Hamartin in Mouse Model of Tuberous Sclerosis T https://t.co/j